Publish Date: 
Friday, January 28, 2022 - 10:45


The Bridge Program equips researchers and entrepreneurs with the knowledge, skills and networks to successfully commercialise new pharmaceuticals. Delivered by QUT, the Bridge Program is supported by a consortium of partners including leading pharmaceutical companies, universities, and industry affiliates. It leverages partner expertise and global connections to equip you with the skills and networks you need to take new medicines to market.

Who should apply?

Up to 100 participants are selected annually from across Australia. The program is suited to mid-career professionals looking to expand their commercialisation knowledge and networks including:

  • researchers
  • scientists
  • entrepreneurs
  • clinicians
  • venture capitalists
  • legal practitioners including IP lawyers and patent attorneys
  • business development professionals
  • staff from regulatory and government agencies

A background in pharmaceutical biotech and a demonstrated interest in a commercialisation career is essential.

Why participate?

  • Access interactive online learning materials delivered by QUT at your own pace from anywhere around Australia.
  • Connect with industry leaders in the Australian biotech ecosystem, and network with an alumni community of over 700 industry professionals at events like our three-day residential Symposium.
  • Learn from the experts through our seminar series, presented by some of the biggest names in the business.
  • Pitch your ideas and receive real-world feedback from industry experts in our pitch competion. Winners receive a fully-funded industry immersion experience.
  • Access opportunities including our REDI Industry Fellowships Program and Life Sciences Innovation Export Hub.
  • There are no fees. Our program is completely funded by industry partners and government as part of an initiative to grow Australia’s pharmaceutical and biotech industry capabilities.

Applications for 2022 are now open! Learn more about the program and apply: